Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Pitts

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Physiological Zoology|September 1, 1997
Sodium economy in white-tailed deer (Odocoileus virginianus)E C Hellgren, W J Pitts
Journal of Cutaneous Pathology|June 1, 1981
Sebaceous adenocarcinomaW H Wilborn, W J Pitts, L F Montes
Biochemistry|January 30, 1996
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenaseJ P Davis, G A Cain, W J Pitts, et al.
Experimental Cell Research|October 20, 2001
Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cellsH R Salih, G C Starling, M Knauff, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of alphavbeta3 antagonists lead compoundsA L Rockwell, M Rafalski, W J Pitts, et al.
Journal of Medicinal Chemistry|January 14, 2000
Isoxazolines as potent antagonists of the integrin alpha(v)beta(3)W J Pitts, J Wityak, J M Smallheer, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogsD J Pinto, D G Batt, W J Pitts, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar SodiumW J Pitts, J W Jetter, D J Pinto, et al.
The Journal of Biological Chemistry|July 11, 1998
Identification of a novel inhibitor of mitogen-activated protein kinase kinaseM F Favata, K Y Horiuchi, E J Manos, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Physiological Zoology|September 1, 1997
Sodium economy in white-tailed deer (Odocoileus virginianus)E C Hellgren, W J Pitts
Journal of Cutaneous Pathology|June 1, 1981
Sebaceous adenocarcinomaW H Wilborn, W J Pitts, L F Montes
Biochemistry|January 30, 1996
The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenaseJ P Davis, G A Cain, W J Pitts, et al.
Experimental Cell Research|October 20, 2001
Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cellsH R Salih, G C Starling, M Knauff, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Rapid synthesis of RGD mimetics with isoxazoline scaffolds on solid phase: identification of alphavbeta3 antagonists lead compoundsA L Rockwell, M Rafalski, W J Pitts, et al.
Journal of Medicinal Chemistry|January 14, 2000
Isoxazolines as potent antagonists of the integrin alpha(v)beta(3)W J Pitts, J Wityak, J M Smallheer, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogsD J Pinto, D G Batt, W J Pitts, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar SodiumW J Pitts, J W Jetter, D J Pinto, et al.
The Journal of Biological Chemistry|July 11, 1998
Identification of a novel inhibitor of mitogen-activated protein kinase kinaseM F Favata, K Y Horiuchi, E J Manos, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.
Pageof 1